Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Matteo Mazzola"'
Publikováno v:
Vascular pharmacology. 145
Porto-pulmonary arterial hypertension (PoPAH) is a form of pulmonary arterial hypertension (PAH) that affects patients with cirrhosis, and - to a lesser extent - patients with non-cirrhotic liver diseases. Compared with other forms of PAH, PoPAH is m
Autor:
Matteo Mazzola, Rosalinda Madonna, Silvia Fabiani, Riccardo Morganti, Arianna Forniti, Francesco Menichetti, Raffaele De Caterina
Publikováno v:
Vascular Pharmacology. 146:107026
Autor:
Nicola Riccardo Pugliese, Matteo Mazzola, Rosalinda Madonna, Luna Gargani, Nicolò De Biase, Frank L. Dini, Stefano Taddei, Raffale De Caterina, Stefano Masi
Publikováno v:
Vascular Pharmacology. 144:106978
Pathophysiological mechanisms behind cardio-pulmonary impairment in heart failure (HF) with reduced (HFrEF) and preserved (HFpEF) ejection fraction are likely different. We analysed them using combined cardiopulmonary-exercise stress echocardiography
Autor:
Matteo Mazzola, Francesco Menichetti, Silvia Fabiani, Arianna Forniti, Riccardo Morganti, Raffaele De Caterina, Rosalinda Madonna
Exercise-induced pulmonary hypertension (Ex-PH) may represent the earliest sign of pulmonary arterial hypertension (PAH) in human immunodeficiency virus (HIV) patients. We investigated its association with clinical and immunological status, virologic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6663dca4586007ee151947cd1da5eec
http://hdl.handle.net/11568/1115442
http://hdl.handle.net/11568/1115442